Back to top
Top

Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients

Receive updates on this topic

eCQMs for 2020 Performance Period

CMS2v9
CMS22v8
CMS50v8
CMS56v8
CMS66v8
CMS68v9
CMS69v8
CMS74v9
CMS75v8
CMS90v9
CMS117v8
CMS122v8
CMS124v8
CMS125v8
CMS127v8
CMS128v8
CMS129v9
CMS130v8
CMS131v8
CMS133v8
CMS134v8
CMS135v8
CMS136v9
CMS137v8
CMS138v8
CMS139v8
CMS142v8
CMS143v8
CMS144v8
CMS145v8
CMS146v8
CMS147v9
CMS149v8
CMS153v8
CMS154v8
CMS155v8
CMS156v8
CMS157v8
CMS159v8
CMS161v8
CMS165v8
CMS177v8
CMS249v2
CMS347v3
CMS349v2
CMS645v3
CMS771v1
CMS Measure ID
CMS129v9
Version
9
NQF Number
0389e
Measure Description

Percentage of patients, regardless of age, with a diagnosis of prostate cancer at low (or very low) risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy who did not have a bone scan performed at any time since diagnosis of prostate cancer

Initial Population

All patients, regardless of age, with a diagnosis of prostate cancer

Denominator Statement

Equals Initial Population at low (or very low) risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy

Denominator Exclusions

None

Numerator Statement

Patients who did not have a bone scan performed at any time since diagnosis of prostate cancer

Numerator Exclusions

Not Applicable

Denominator Exceptions

Documentation of reason(s) for performing a bone scan (including documented pain, salvage therapy, other medical reasons, bone scan ordered by someone other than reporting physician)

Measure Steward
PCPI(R) Foundation (PCPI[R])
Domain
Efficiency and Cost Reduction
Previous Version
CMS129v8
Measure Scoring
Proportion
Measure Type
Process
Improvement Notation

Higher score indicates better quality

Guidance

A higher score indicates appropriate treatment of patients with prostate cancer at low (or very low) risk of recurrence. Only patients with prostate cancer with low (or very low) risk of recurrence will be counted in the performance denominator of this measure.

Quality ID
102
Meaningful Measure
Appropriate Use of Healthcare

Specifications

Attachment Size
CMS129v9.html 53.93 KB
CMS129v9.zip 34.88 KB
CMS129v9-TRN.xlsx 21.63 KB

Data Element Repository

Release Notes

Header

  • Updated eCQM version number.

    Measure Section: eCQM Version number

    Source of Change: Measure Lead

  • Added 'e' to NQF number.

    Measure Section: NQF Number

    Source of Change: Standards Update

  • Updated description statement with removal of references to cryotherapy to align with the updated guideline.

    Measure Section: Description

    Source of Change: Expert Work Group Review

  • Updated copyright.

    Measure Section: Copyright

    Source of Change: Annual Update

  • Updated disclaimer.

    Measure Section: Disclaimer

    Source of Change: Measure Lead

  • Updated rationale statement with in-text citation date to reflect updated reference.

    Measure Section: Rationale

    Source of Change: Measure Lead

  • Updated clinical recommendation statement to align with current guidelines.

    Measure Section: Clinical Recommendation Statement

    Source of Change: Measure Lead

  • Updated references to align with American Psychological Association (APA) style.

    Measure Section: Reference

    Source of Change: Measure Lead

  • Updated references.

    Measure Section: Reference

    Source of Change: Measure Lead

  • Updated definition statement to align with current guideline.

    Measure Section: Definition

    Source of Change: Measure Lead

  • Updated denominator statement with removal of references to cryotherapy from the denominator statement to align with updated guideline.

    Measure Section: Denominator

    Source of Change: Expert Work Group Review

  • Updated parenthetical citations to align with American Psychological Association (APA) style.

    Measure Section: Multiple Sections

    Source of Change: Measure Lead

Logic

  • Replaced value set Cancer Staging (2.16.840.1.113883.3.526.3.1536) with direct reference code SNOMED CT code (258232002).

    Measure Section: Denominator

    Source of Change: Measure Lead

  • Updated the names of Clinical Quality Language (CQL) definitions, functions, and/or aliases for clarification and to align with CQL Style Guide.

    Measure Section: Definitions and Functions

    Source of Change: Standards Update

  • Updated Clinical Quality Language (CQL) expression to conform with the HL7 Standard: Clinical Quality Language Specification, Release 1 STU 3 (CQL 1.3).

    Measure Section: Multiple Sections

    Source of Change: Standards Update

Value Set

The VSAC is the source of truth for the value set content, please visit the VSAC for downloads of current value sets.

  • Value set Prostate Cancer Treatment (2.16.840.1.113883.3.526.3.398): Deleted 1 CPT code (55873). Added 2 SNOMED CT codes (427541000119103, 764675000) and deleted 8 SNOMED CT codes (169374002, 176319004, 265589001, 29860002, 420529003, 427357007, 433225000, 64978007).

    Measure Section: Terminology

    Source of Change: Annual Update

  • Value set Pain Related to Prostate Cancer (2.16.840.1.113883.3.526.3.451): Deleted 2 ICD-9-CM codes (V76.44, V84.03). Deleted 2 ICD-10-CM codes (Z12.5, Z15.03).

    Measure Section: Terminology

    Source of Change: Annual Update

  • Replaced value set Cancer Staging (2.16.840.1.113883.3.526.3.1536) with direct reference code SNOMED CT code (258232002).

    Measure Section: Terminology

    Source of Change: Measure Lead

  • ​Removed code system versions from direct reference codes. Please refer to Appendix A of the Electronic Clinical Quality Measure Logic and Implementation Guidance document for a list of code system versions used in the eCQM specifications for 2020 reporting/performance.

    Measure Section: Terminology

    Source of Change: Standards Update

  • Standardized purpose statement language in value sets across eCQMs. Value set purpose statements are visible in the Value Set Authority Center (VSAC) as well as the downloadable eCQM value set files.

    Measure Section: Terminology

    Source of Change: Measure Lead

External Resources

United States Health Information Knowledgebase
NLM Value Set Authority Center (VSAC)
Last Updated: Feb 26, 2020